Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Expert Review of Hematology|October 29, 2014
Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factorsNicolas Duployez, Christophe Willekens, Alice Marceau-Renaut, et al.
Pediatric Blood & Cancer|April 21, 2020
Association of fludarabin, cytarabine, and fractioned gemtuzumab followed by hematopoietic stem cell transplantation for first-line refractory acute myeloid leukemia in children: A single-center experienceMathilde Penel-Page, Adriana Plesa, Sandrine Girard, et al.
Bone Marrow Transplantation|January 9, 2022
Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case reportMichael Loschi, Christian Roux, Isabelle Sudaka, et al.
Hematology (Amsterdam, Netherlands)|May 27, 2022
AML with inv(16)/t(16;16) and high-risk cytogenetic abnormalities: atypical features and unfavorable outcomeNada Assaf, Christine Lefebvre, Victoria Raggueneau, et al.
European Journal of Haematology|October 17, 2017
Detection of a new heterozygous germline ETV6 mutation in a case with hyperdiploid acute lymphoblastic leukemiaNicolas Duployez, Wadih Abou Chahla, Sophie Lejeune, et al.
Leukemia Research|October 16, 2015
Quantification of EVI1 transcript levels in acute myeloid leukemia by RT-qPCR analysis: A study by the ALFA GroupThomas Smol, Olivier Nibourel, Alice Marceau-Renaut, et al.
British Journal of Haematology|December 19, 2025
Assessment of measurable residual disease in ovarian tissue collected for fertility preservation in patients in remission from acute myeloid leukaemia: A pilot studyAugustin Boudry, Florian Chevillon, Alice Marceau-Renaut, et al.
American Journal of Hematology|March 12, 2014
Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNANicolas Duployez, Olivier Nibourel, Alice Marceau-Renaut, et al.
Haematologica|February 24, 2018
Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA groupYann Ferret, Nicolas Boissel, Nathalie Helevaut, et al.
British Journal of Haematology|September 3, 2025
Monitoring of measurable residual disease by next-generation sequencing in patients with acute myeloid leukaemiaAugustin Boudry, Laure Goursaud, Delphine Lebon, et al.
Pageof 3